There is increased awareness of the negative impact of large multinational corporations - the 'industry' - on public health. These corporations have established different types of relationships with a number of actors in the field of health research. This Commentary explores the different types of relationships between the industry and the actors of health research, how they intersect with the different research steps, and how these relationships allow the industry to exert influence. The types of relationships discussed consist of funding of research, direct relationships with the actors of research (namely advocacy groups, funding agencies, experts, professional organisations, regulatory agencies and health practitioners), and the influencing research standards. The potentially influenced research steps either precede the research (i.e. the prioritisation of research question), relate to it directly (i.e. its planning, conduct, reporting, dissemination and evaluation), or build on it (i.e. regulatory approval, integration into guidelines and adoption into practice). In conclusion, the industry has successfully fostered relationships with almost every actor of the health research enterprise and is using these relationships to influence the different steps of health research. The degree of influence the industry is having on health research calls for more work on managing the relationships discussed herein.

中文翻译：

---

行业与健康研究企业的交叉点。


人们越来越意识到大型跨国公司（“行业”）对公共卫生的负面影响。这些公司与健康研究领域的许多参与者建立了不同类型的关系。本评论探讨了行业与健康研究参与者之间的不同类型的关系，它们如何与不同的研究步骤交叉，以及这些关系如何让行业发挥影响力。讨论的关系类型包括研究资助、与研究参与者（即倡导团体、资助机构、专家、专业组织、监管机构和卫生从业者）的直接关系以及影响研究标准。潜在影响的研究步骤要么先于研究（即研究问题的优先顺序），要么直接与研究相关（即其规划、实施、报告、传播和评估），要么建立在研究之上（即监管部门批准、纳入指南和采用）付诸实践）。总之，该行业已成功地与健康研究企业的几乎每个参与者建立了关系，并利用这些关系来影响健康研究的不同步骤。该行业对健康研究的影响程度要求在管理本文讨论的关系方面开展更多工作。